Cookie use policy in HMR

This website uses cookies to ensure functionality for better navigation.
Filmography By continuing to browse, you consent to the use of cookies and the new terms and conditions of privacy.




hmR acquires majority share in ActOne, SA

The agreement contributes to the enhancement of the business and to the strengthening of the ambition of expansion for the various European markets. 

As part of its strategic business growth and development plan, hmR acquired a 76% share in ActOne, SA. With this acquisition, we intend to provide added value to the clients of both organisations, for the complementary services offered and for the joint experience of both companies in the markets where they operate. This operation will also accelerate the implementation of the strategic vision of shareholders regarding the positioning and ambitions for the European market.

hmR is a company that specialises in the generation of knowledge and consulting services, which is essential for the decision-making support of companies operating in the health sector, based on data collected in pharmacies, health spaces and the hospital environment. 

ActOne is a company dedicated exclusively to the health sector, engaging in the development of market studies focused on the analysis of the behaviour of health professionals, and in the development and adaptation of technological solutions geared to the needs of companies operating in this sector.

In this new framework, and considering the experience accumulated in the sector and the deep knowledge of the business and of the clients, the current members of ActOne will be an integral part of the executive management team, continuing to be an active part in monitoring the Company's activity and in pursuit of its strategy.

"This acquisition represents a new step for both companies, with a clear alignment on the desire for sustained business development in key European markets. I would like to highlight the complementarity of the service portfolio of both companies, which will be reflected in the variety, but also in the quality of the service provided to our current and future clients, in the different markets where we are present. Of all ActOne’s assets, I highlight the human capital that its employees represent, which is essential to the future success of this operation,” says João Norte, CEO of hmR.

According to João Maxieira, executive director and founding partner of ActOne, "the possibility of integrating a multinational group, of Portuguese origin, into significant growth, and designing the products and services that we have created so successfully in ActOne for a global reality, is an opportunity we should take advantage of. The full complementarity of the offer and the access to a dynamic, solid and ethical structure will enable us to design our offer with high efficiency and to create value and diversity for the client, as well as internal opportunities, thus developing a superior set of shares."

The same opinion is shared by Cláudio Costa, CEO and founding partner of ActOne: "we found in hmR a solid team that shares the same values and the same desire to transform innovation into a constant variable in the present and in the future. This is an opportunity and an evolutionary step for both companies, which have as their genesis the ambition to become true global partners in the health area. It will also undoubtedly be a great opportunity for all our clients, as they will benefit from the usual quality, commitment and dedication of hmR and ActOne, with the synergistic addition that I believe will happen."

About hmR - Health Market Research

hmR - Health Market Research is a multinational company, of Portuguese origin, founded in 2009, that specialises in the generation of knowledge and consulting services for the health industry. It is currently present in Portugal, Spain, Ireland and Germany.

At hmR, the clients, whom we seek consistently to provide the best level of support for decision-making, are our priority.

At hmR, we work to continuously exceed the quality and speed of delivery to our clients.

For more information visit:

About ActOne, SA 

Founded in 2009, ActOne, SA, is a company dedicated to the development of services and products exclusively for the pharmaceutical industry. It currently has 30 employees, having presented, over the years, a significant sustained growth in the continuous launch of innovative products and services and the development of a relationship of trust with clients, always focusing on the pillars of differentiation and quality and the consequent creation of value for the client.

ActOne bases its development model on the construction of new products and services, having a Business Development unit entirely dedicated to the construction of new offers, in a search to be positioned, and to be seen by the client, as a partner capable of producing a differentiating offer that supports the development of your business.

For more information visit:

Additional Information:
Pedro Figueiredo